HomeInsightsStock Comparison

Nectar Lifescience Ltd vs Zim Laboratories Ltd Stock Comparison

Nectar Lifescience Ltd vs Zim Laboratories Ltd Stock Comparison

Last Updated on: May 05, 2025

Key Highlights

  • The Latest Trading Price of Nectar Lifescience Ltd is ₹ 21.91 as of 05 May 09:42.
  • The P/E Ratio of Nectar Lifescience Ltd changed from 7 on March 2020 to 136.9 on March 2024 . This represents a CAGR of 81.24% over 5 yearsThe P/E Ratio of Zim Laboratories Ltd changed from 27.4 on March 2020 to 27 on March 2024 . This represents a CAGR of -0.29% over 5 years.
  • The Market Cap of Nectar Lifescience Ltd changed from ₹ 221.79 crore on March 2020 to ₹ 675.25 crore on March 2024 . This represents a CAGR of 24.94% over 5 yearsThe Market Cap of Zim Laboratories Ltd changed from ₹ 90.53 crore on March 2020 to ₹ 465.33 crore on March 2024 . This represents a CAGR of 38.74% over 5 years.
  • The revenue of Nectar Lifescience Ltd for the Dec '24 is ₹ 455.56 crore as compare to the Sep '24 revenue of ₹ 428.79 crore. This represent the growth of 6.24% The revenue of Zim Laboratories Ltd for the Dec '24 is ₹ 98.08 crore as compare to the Sep '24 revenue of ₹ 93.46 crore. This represent the growth of 4.94%.
  • The ebitda of Nectar Lifescience Ltd for the Dec '24 is ₹ 45.28 crore as compare to the Sep '24 ebitda of ₹ 44.02 crore. This represent the growth of 2.86% The ebitda of Zim Laboratories Ltd for the Dec '24 is ₹ 13.32 crore as compare to the Sep '24 ebitda of ₹ 10.85 crore. This represent the growth of 22.76%.
  • The net profit of Nectar Lifescience Ltd changed from ₹ 1.82 crore to ₹ 7.84 crore over 7 quarters. This represents a CAGR of 130.37% The net profit of Zim Laboratories Ltd changed from ₹ 0.23 crore to ₹ 4 crore over 7 quarters. This represents a CAGR of 411.40% .
  • The Dividend Payout of Nectar Lifescience Ltd changed from 3.73 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Zim Laboratories Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Nectar Lifescience Ltd

  • Nectar Lifescience Limited was incorporated on June 27, 1995 with the name 'Surya Medicare Limited'.
  • On March 26, 2004, Company changed their name from 'Surya Medicare Limited' to 'Nectar Lifescience Limited'.
  • NECLIFE is an integrated pharmaceutical organization, engaged in manufacturing and delivering high quality pharmaceutical products.
  • It is a global pharmaceutical company specializing in Cephalosporins.
  • Nectar excels in Cephalosporin APIs production with certified facilities meeting global standards.

About Zim Laboratories Ltd

  • Zim Laboratories Ltd was incorporated in February, 1984 under the name and style of Zim Laboratories Private Limited in the State of Maharashtra.
  • The Company became a Public Limited Company through fresh Certificate of Incorporation issued by the Registrar of Companies, Maharashtra, Mumbai.
  • The Company is engaged in the manufacturing of formulation on drugs and pre formulation ingredients in India and marketing and selling these within and outside India.
  • The Pharma Industry is dominated by Multinationals, Large Indian companies and in the lower end of the market large number of units mainly in the SSI sector. During the year 2019-20, ZIM Health Technologies Limited was acquired thereby resulting as a wholly owned subsidiary of the company.
  • SIA ZIM Laboratories Limited got incorporated as a wholly owned subsidiary in Latvia.

Nectar Lifescience Ltd News Hub

News

Nectar Lifesciences slumps after Mohali unit gets seven observations from EU authorities

In a regulatory filing made after market hours yesterday, the company stated that its API ...

Read more

11 Mar 2025 12:24

News

Nectar Lifescience announces board meeting date

Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 31 Janu...

Read more

24 Jan 2025 16:30

News

Nectar Lifescience schedules board meeting

Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 14 Nove...

Read more

04 Nov 2024 16:03

News

Nectar Lifescience to conduct AGM

Nectar Lifescience announced that the Annual General Meeting (AGM) of the company will be ...

Read more

20 Aug 2024 16:12

News

Nectar Lifescience to convene AGM

Nectar Lifescience announced that the Annual General Meeting (AGM) of the company will be ...

Read more

20 Aug 2024 10:47

News

Nectar Lifescience to conduct board meeting

Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 14 Augu...

Read more

06 Aug 2024 16:18

Zim Laboratories Ltd News Hub

News

Zim Laboratories partners with UAE-based Globalpharma Co.

Zim Laboratories (ZIM) has entered into a Dossier License, Product Supply, and Technology ...

Read more

09 Apr 2025 20:57

News

Zim Labs gets regulatory nod in Portugal for multiple sclerosis treatment drug Dimethyl Fumarate

This authorization from INFARMED, which is the Portuguese National Authority of Medicines ...

Read more

20 Mar 2025 12:53

News

Zim Laboratories to declare Quarterly Results

Zim Laboratories will hold a meeting of the Board of Directors of the Company on 10 Februa...

Read more

04 Feb 2025 15:18

News

ZIM Lab and Neuraxpharm announces grant of marketing authorization for Buprenorphine Sublingual Film in Europe

ZIM Laboratories and Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmac...

Read more

11 Jan 2025 09:56

News

Zim Laboratories incorporates step-down subsidiary in Dubai

Zim Laboratories announced that the step-down Subsidiary has been incorporated in the name...

Read more

16 Nov 2024 12:56

News

Zim Laboratories to conduct board meeting

Zim Laboratories will hold a meeting of the Board of Directors of the Company on 9 Novembe...

Read more

05 Nov 2024 14:07

SWOT Analysis Of Nectar Lifescience Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Zim Laboratories Ltd

Strength

0

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Nectar Lifescience Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Zim Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Nectar Lifescience Ltd and Zim Laboratories Ltd

Which company has a larger market capitalization, Nectar Lifescience Ltd or Zim Laboratories Ltd?

Market cap of Nectar Lifescience Ltd is 489 Cr while Market cap of Zim Laboratories Ltd is 426 Cr

What are the key factors driving the stock performance of Nectar Lifescience Ltd and Zim Laboratories Ltd?

The stock performance of Nectar Lifescience Ltd and Zim Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Nectar Lifescience Ltd and Zim Laboratories Ltd?

As of May 5, 2025, the Nectar Lifescience Ltd stock price is INR ₹21.81. On the other hand, Zim Laboratories Ltd stock price is INR ₹87.57.

How do dividend payouts of Nectar Lifescience Ltd and Zim Laboratories Ltd compare?

To compare the dividend payouts of Nectar Lifescience Ltd and Zim Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions